Biotika a.s. (BSSE:1BSL01AE)
 9.00
 0.00 (0.00%)
  At close: Oct 28, 2025
Biotika a.s. Income Statement
Financials in millions EUR. Fiscal year is January - December.
 Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 | 
|---|---|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 | 
| Operating Revenue | 18.18 | 16.76 | 22.07 | 11.03 | 8.91 | 17.65 | Upgrade  | 
| Other Revenue | 0.48 | 0.48 | 1.06 | - | - | - | Upgrade  | 
| 18.66 | 17.24 | 23.13 | 11.03 | 8.91 | 17.65 | Upgrade  | |
| Revenue Growth (YoY) | 62.34% | -25.46% | 109.66% | 23.83% | -49.53% | -32.98% | Upgrade  | 
| Cost of Revenue | 14.37 | 12.15 | 15.3 | 8.52 | 16.09 | 17.1 | Upgrade  | 
| Gross Profit | 4.29 | 5.09 | 7.82 | 2.51 | -7.19 | 0.55 | Upgrade  | 
| Selling, General & Admin | 5.74 | 6 | 5.65 | 4.78 | 0.02 | 0.02 | Upgrade  | 
| Other Operating Expenses | 0.59 | 0.74 | 0.62 | -2.76 | -7.67 | -1.63 | Upgrade  | 
| Operating Expenses | 8.14 | 8.58 | 7.77 | 3.54 | -7.66 | -1.61 | Upgrade  | 
| Operating Income | -3.85 | -3.49 | 0.06 | -1.04 | 0.47 | 2.16 | Upgrade  | 
| Interest Expense | -0.03 | -0 | - | -0 | - | - | Upgrade  | 
| Interest & Investment Income | - | - | - | 0.26 | 0.04 | 0.57 | Upgrade  | 
| Currency Exchange Gain (Loss) | 0.03 | 0.01 | -0.01 | -0.02 | - | - | Upgrade  | 
| Other Non Operating Income (Expenses) | -0.02 | - | - | -0.01 | - | - | Upgrade  | 
| EBT Excluding Unusual Items | -3.88 | -3.48 | 0.04 | -0.8 | 0.51 | 2.73 | Upgrade  | 
| Gain (Loss) on Sale of Investments | 0.2 | 0.51 | 0.08 | - | - | - | Upgrade  | 
| Gain (Loss) on Sale of Assets | 0.39 | 0.15 | 0.1 | - | - | - | Upgrade  | 
| Asset Writedown | - | - | - | -0.04 | - | - | Upgrade  | 
| Pretax Income | -3.29 | -2.83 | 0.22 | -0.84 | 0.51 | 2.73 | Upgrade  | 
| Income Tax Expense | -0.44 | -0.44 | -0.15 | -0.02 | 0.11 | 0.45 | Upgrade  | 
| Net Income | -2.86 | -2.39 | 0.37 | -0.82 | 0.41 | 2.28 | Upgrade  | 
| Net Income to Common | -2.86 | -2.39 | 0.37 | -0.82 | 0.41 | 2.28 | Upgrade  | 
| Net Income Growth | - | - | - | - | -82.17% | 12.55% | Upgrade  | 
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | - | Upgrade  | 
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | - | Upgrade  | 
| EPS (Basic) | -4.08 | -3.41 | 0.53 | -1.17 | 0.58 | - | Upgrade  | 
| EPS (Diluted) | -4.08 | -3.41 | 0.53 | -1.17 | 0.58 | - | Upgrade  | 
| Free Cash Flow | -1.59 | -2.56 | 0.65 | -0.08 | 0.04 | 3.17 | Upgrade  | 
| Free Cash Flow Per Share | -2.27 | -3.66 | 0.93 | -0.12 | 0.06 | - | Upgrade  | 
| Dividend Per Share | - | - | - | - | 0.500 | 2.600 | Upgrade  | 
| Dividend Growth | - | - | - | - | -80.77% | 13.04% | Upgrade  | 
| Gross Margin | 22.99% | 29.52% | 33.83% | 22.73% | -80.67% | 3.09% | Upgrade  | 
| Operating Margin | -20.65% | -20.26% | 0.24% | -9.40% | 5.29% | 12.23% | Upgrade  | 
| Profit Margin | -15.31% | -13.86% | 1.60% | -7.43% | 4.55% | 12.90% | Upgrade  | 
| Free Cash Flow Margin | -8.53% | -14.86% | 2.81% | -0.73% | 0.44% | 17.97% | Upgrade  | 
| EBITDA | -2.44 | -2.15 | 1.36 | 0.28 | 1.86 | 4.28 | Upgrade  | 
| EBITDA Margin | -13.08% | -12.49% | 5.89% | 2.50% | 20.87% | 24.24% | Upgrade  | 
| D&A For EBITDA | 1.41 | 1.34 | 1.31 | 1.31 | 1.39 | 2.12 | Upgrade  | 
| EBIT | -3.85 | -3.49 | 0.06 | -1.04 | 0.47 | 2.16 | Upgrade  | 
| EBIT Margin | -20.65% | -20.26% | 0.24% | -9.40% | 5.29% | 12.23% | Upgrade  | 
| Effective Tax Rate | - | - | - | - | 21.17% | 16.58% | Upgrade  | 
| Revenue as Reported | 10.62 | 12.15 | 16.18 | 14.29 | 16.58 | 19.28 | Upgrade  | 
Source: S&P Global Market Intelligence. Standard template. Financial Sources.